At a glance
Studies Addressing Rare Neurodegenerative Diseases including ALS is a federal competitive grant from Food and Drug Administration for the science & technology sector. Eligible applicants: State governments; County governments; Special district governments; Small businesses; Native American tribal organizations (other than Federally recognized tribal governments); Private institutions of higher education;. Applications are accepted on a rolling basis. Apply via the official listing at www.grants.gov.
- Amount
- See listing
- Deadline
- Rolling
- Type
- Competitive
- Status
- Forecasted
About this program
The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.
Who can apply
State governments; County governments; Special district governments; Small businesses; Native American tribal organizations (other than Federally recognized tribal governments); Private institutions of higher education; City or township governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal governments (Federally recognized); Independent school districts; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; Public and State controlled institutions of higher education; Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"; Public housing authorities/Indian housing authorities
How to apply
Apply through Grants.gov using funding opportunity number FOR-FD-25-006. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.
Apply at official sourceRelated grants
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) NIH · See listing · Jan 7, 2028 Open
- Cannabis Research and Innovation Funding Opportunity (RIFO) Department of Fish and Wildlife · Dependant on number of submissions received, application process, etc. · Rolling Open
- ROSES 2025: A.16 Cryosphere NASA · $2K–$10B · Dec 4, 2026 Open
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) NIH · See listing · Jan 7, 2028 Open